Mr. Speaker, in response to (a), from March 8 to May 7, 2021, Health Canada consulted Canadians on a draft guidance document on factors the department may consider when using the authorities provided by the cannabis regulations to refuse, renew, amend or revoke a registration for personal and designated production of cannabis for medical purposes.
The consultation has since concluded. Health Canada received 677 responses to the consultation through an online questionnaire or email. The department is analyzing the feedback and is currently preparing a report that summarizes the consultation comments and a final version of the guidance document, both of which will be published on the Health Canada website.
Section 151.1 of the Cannabis Act requires that the minister of health cause a review of the act and its administration and operation three years after coming into force (i.e., after October 17, 2021), and that a report, including any findings or recommendations resulting from the review, be tabled in both Houses of Parliament within 18 months.
In response to (b)(i), as set out in the legislation, the legislative review must study the impact of the act on public health. In particular, it must look at the impact on the health and consumption habits of young persons with respect to cannabis use, the impact of cannabis on indigenous persons and communities, and the impact of the cultivation of cannabis plants in a dwelling-house.
The government is committed to putting into place a credible, evidence-driven process for the legislative review, which will assess the progress made towards achieving the objectives of the act. Preparations are under way for the launch of the review.
In response to (b)(ii), briefing note 21-111407-100 M2M, “Preparations for the Cannabis Act Legislative Review”, can be consulted for further detail.